David Peltier

 

David Peltier joined TheStreet as a research associate in August 2001, and writes TheStreet Stocks Under $10. Before that, Peltier was an analyst for Individual Investor magazine and the publication's Web site. His market interests include small-caps, technology and retail stocks. He has appeared on NPR, NBR and WNYW-TV.

Peltier received his bachelor's degree cum laude in finance and international business from New York University.

 

----------

 

A Note From David: My name is David Peltier. I manage a much-followed portfolio for TheStreet called Stocks Under $10 -- the unique investment service that alerts you to what I believe are deeply undervalued stocks with tremendous growth potential.

 

I've made it my life's work to help investors like you build lasting wealth by investing in only the very best small company stocks.

 

Because it's these little-known companies, which are overlooked by much of Wall Street, that could break out and double or even triple your money!

 

Start Your 14-Day Free Trial of Stocks Under $10.

 


Recent Articles By The Author

Removing Retailer From Bullpen

We no longer see upside in Buckle, given deteriorating business fundamentals.

Cutting Ballantyne Position and Rating

We are selling half of our BTN shares into strength and reducing our rating to Three.

Sonus Networks Cuts a Deal

It has acquired privately held telecom equipment maker Taqua in a transaction that should be accretive to earnings next year.

Putting 2 Biotechs Under the Microscope

These low-dollar biotech stocks are making big moves Monday -- in opposite directions.

Pfizer Nixes Business Split, Despite Activist Pressure

The company now believes that it makes more sense to keep its established drug and clinical products businesses under one roof.